Management of COVID-19-A Review
Anti-Infective Agents
; 20(2), 2022.
Article
in English
| EMBASE | ID: covidwho-1938561
ABSTRACT
Coronavirus disease-2019 (COVID-19) has gained much popularity not only in the Wuhan city of China but internationally also;in January 2020, the corona rapidly spread to many countries like the USA, Italy, Russia, India, Singapore, Pakistan, Thailand, Canada, Australia, England, and so on through passengers traveling to other countries. Corona patients can be cured with synthetic drugs, traditional herbal medicines (THM), use of Vitamin D and the quarantine approach. Different allopathic medicines, herbal extracts, and vitamin D have been observed to be useful in the treatment of novel coronavirus, like Remdesivir, hydroxychloroquine, Teicoplanin, Lopinavir+ Ritonavir, Ribavirin + corticosteroids, Glycyrrhizin, Sanguisorbae radix, Acanthopanacis cortex, Sophorae radix, etc. Various antiviral drugs are used to treat COVID-19, alone or in combination with other medications like Interferon-α, Lopinavir + Ritonavir, Arbidol, corticosteroids, etc., and some herbal extracts;also quarantine approach and Vitamin D are used that not only cure the infection but also boost up our immunity. For this review article, different papers were searched on Google Scholar, Scopus, WHO’s website, PubMed, clinicaltrials.gov and other relevant scientific research websites. In this review article, we have discussed the current strategies that are being used to treat COVID-19. Along with allopathic drugs, some herbal extracts can also be used to treat this novel coronavirus, like Glycyrrhizin, Sanguisorbae radix, Acanthopanacis cortex, Sophorae radix, etc. and even vitamin D.
alisporivir; alpha interferon; angiotensin converting enzyme 2; antivirus agent; beta interferon; calcitriol; chloroquine; chlorpromazine; corticosteroid; cyclosporine; gamma interferon; glycyrrhizic acid; granulocyte colony stimulating factor; hydroxychloroquine; interleukin 13; loperamide; lopinavir; notazoxanide; remdesivir; ribavirin; ritonavir; sanguisorbae radix; scatter factor; teicoplanin; umifenovir; unclassified drug; vitamin D; vitamin D receptor; antigen presenting cell; antimicrobial activity; atherosclerosis; B lymphocyte; cell differentiation; China; chronic obstructive lung disease; chronology; coronavirus disease 2019; cytokine production; cytokine storm; dendritic cell; DNA repair; extracellular trap; gap junction; glycosylation; herbal medicine; human; Human immunodeficiency virus 1; hypertension; immune response; immunity; immunocompetence; innate immunity; macrophage; neutrophil; Pakistan; phagocytosis; pneumonia; posttraumatic stress disorder; quarantine; review; SARS coronavirus; sun exposure; systematic review; T lymphocyte; Th17 cell; ulcerative colitis; virus infection; virus replication; vitamin supplementation
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Anti-Infective Agents
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS